In summary, we present evidence of great clinical variability associated with homozygous mutations in BEST1. Other factors, genetic or environmental, could modulate the phenotype in these families, since the retinopathy in the presented patients is not identical even within the same families. Here, BEST1 is linked to retinal disorder.